Cleared Traditional

UNiD Spine Analyzer (K212005) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212005 · Medicrea International, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
198d
Days
Class 2
Risk

K212005 is an FDA 510(k) clearance for the UNiD Spine Analyzer. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Medicrea International, Inc. (Rilleux La Pape, FR). The FDA issued a Cleared decision on January 12, 2022 after a review of 198 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Medicrea International, Inc. devices

Submission Details

510(k) Number K212005 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2021
Decision Date January 12, 2022
Days to Decision 198 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d slower than avg
Panel avg: 107d · This submission: 198d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Sterling Medical Devices
Teal Bjoraker

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 819
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K212005.
Rapid
K213165 · Ischemaview, Inc. · Feb 2022
Veuron-Brain-pAb2
K213801 · Heuron Co., Ltd. · Feb 2022
Quantib ND
K213737 · Quantib B.V. · Jan 2022
AIBOLIT 3D+
K211443 · Aibolit Technologies, LLC · Jan 2022
VUZE System
K210830 · Vuze Medical , Ltd. · Jan 2022
CONVIVO In Vivo Pathology Suite
K211156 · Carl Zeiss Meditec, AG · Dec 2021